3,4-dihydroxyphenylacetic acid has been researched along with Neuromuscular Diseases in 3 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rekha, KR | 1 |
| Selvakumar, GP | 1 |
| Santha, K | 1 |
| Inmozhi Sivakamasundari, R | 1 |
| Dang, MT | 1 |
| Yokoi, F | 1 |
| Pence, MA | 1 |
| Li, Y | 1 |
| Tollefson, GD | 1 |
| Garvey, MJ | 1 |
3 other studies available for 3,4-dihydroxyphenylacetic acid and Neuromuscular Diseases
| Article | Year |
|---|---|
Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Acyclic Monoterpenes; | 2013 |
Motor deficits and hyperactivity in Dyt1 knockdown mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alleles; Animals; Blotting, Western; Dopamine; Exons; Genetic Vector | 2006 |
The neuroleptic syndrome and central dopamine metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antipsychotic Agents; Basal Ganglia Diseases; Dopamine; Female; Homo | 1984 |